Compare Oscar Health Inc (OSCR) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while YieldMax TSLA Option Income Strategy ETF trades at $22.45 (market cap $697.51M). The key difference: Oscar Health Inc is far larger — about 14.7× YieldMax TSLA Option Income Strategy ETF's market cap, and Oscar Health Inc is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and YieldMax TSLA Option Income Strategy ETF for 43 Days on average.
| OSCR | TSLY | |
|---|---|---|
Market Cap | $10.22B | $697.51M |
Volume | 4,123,394 | 338,271 |
Sector | Health | Income / Options Overlay |
52-Week High | $33.81 | $43.35 |
52-Week Low | $10.85 | $20.49 |
Typical Hold Time | 15 Days | 43 Days |
Enterprise Value | $6.57B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
TSLY trades at $22.27, down 1.46% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF generates high income through weekly dividends, averaging around $0.21-$0.26 per share recently. Recent news highlights consistent distribution announcements but also notes underperformance versus Tesla's equity rally due to its option income strategy structure.
The outlook is mixed: high yield appeals to income seekers, but the strategy caps upside during Tesla rallies. Key risks include dependence on Tesla's volatility and potential NAV erosion. Investors should weigh income generation against limited capital appreciation potential in a bullish Tesla market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About YieldMax TSLA Option Income Strategy ETF
TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →
